These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4015006)

  • 41. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological versus mechanical prosthesis in 3279 patients from the Swedish in-patients register.
    Hellgren L; Granath F; Ekbom A; Ståhle E
    Scand Cardiovasc J; 2011 Aug; 45(4):223-8. PubMed ID: 21506653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The late results of mitral valve prosthetic replacement with biological and mechanical prostheses].
    Dzemeshkevich SL; Gromova GV; Liudinovskova RA; Kudrina LL; Kovyrialkina OV
    Vestn Akad Med Nauk SSSR; 1987; (5):33-6. PubMed ID: 3617905
    [No Abstract]   [Full Text] [Related]  

  • 44. Current status of porcine heterograft prostheses: a 5-year appraisal.
    Hannah H; Reis RL
    Circulation; 1976 Dec; 54(6 Suppl):III27-31. PubMed ID: 1033047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thromboembolic and haemorrhagic risk in mechanical and biological aortic prostheses.
    Farah E; Enriquez-Sarano M; Vahanian A; Houlegatte JP; Boubaker A; Roger V; Acar J
    Eur Heart J; 1984 Oct; 5 Suppl D():43-7. PubMed ID: 6519101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulant therapy in children with prosthetic valves.
    Rao PS; Solymar L; Mardini MK; Fawzy ME; Guinn G
    Ann Thorac Surg; 1989 Apr; 47(4):589-92. PubMed ID: 2712632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis.
    Nuñez L; Gil Aguado M; Larrea JL; Celemín D; Oliver J
    Ann Thorac Surg; 1984 Jan; 37(1):84-7. PubMed ID: 6691742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboembolic complications of current cardiac valvular prostheses.
    Edmunds LH
    Ann Thorac Surg; 1982 Jul; 34(1):96-106. PubMed ID: 7046665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hemolytic anemia and cardiac heterografts. Apropos of 2 cases].
    Anconina J; Bruntz JF; Audibert G; Hueber A; Zannad F; Villemot JP; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1989 Feb; 82(2):237-9. PubMed ID: 2500085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolated aortic valve replacement with the Björk-Shiley tilting disc prosthesis and the porcine bioprosthesis.
    Egloff L; Rothlin M; Turina M; Senning A
    Eur Heart J; 1980 Apr; 1(2):123-7. PubMed ID: 7285970
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term results (from 5 to 7 years) with the Hancock S-G-P bioprosthesis.
    Casarotto D; Bortolotti U; Thiene G; Gallucci V; CéVese PG
    J Cardiovasc Surg (Torino); 1979; 20(4):399-406. PubMed ID: 479277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thromboembolic and haemorrhagic complications in patients treated with anticoagulants after artificial heart valve replacement. Risk factors dependent on quality of anticoagulant treatment].
    Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
    Pol Arch Med Wewn; 2005 Jul; 114(1):673-80. PubMed ID: 16466014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term outcome of mechanical prostheses].
    Acar J
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):187-9. PubMed ID: 4015003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent systemic embolic events with valve prosthesis.
    Acar J; Enriquez-Sarano M; Farah E; Kassab R; Tubiana P; Roger V
    Eur Heart J; 1984 Oct; 5 Suppl D():33-8. PubMed ID: 6519099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thromboembolic complications of prosthetic cardiac valves.
    Akbarian M; Austen G; Yurchak PM; Scannell JG
    Circulation; 1968 May; 37(5):826-31. PubMed ID: 5300611
    [No Abstract]   [Full Text] [Related]  

  • 56. [Mitral valve replacement in children. Apropos of 176 cases].
    el Makhlouf A; Friedli B; Oberhänsli I; Rouge JC; Faidutti B
    Ann Chir; 1988; 42(2):86-90. PubMed ID: 3369835
    [No Abstract]   [Full Text] [Related]  

  • 57. [Follow-up critical evaluation of mechanical and biological heart valve prostheses].
    Festa M; Santé P; Renzulli A; Micheletti E; Dialetto G; Mancusi S; Cotrufo M
    Arch Monaldi Mal Torace; 1987; 42(2):141-52. PubMed ID: 3505419
    [No Abstract]   [Full Text] [Related]  

  • 58. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
    Cannegieter SC; Rosendaal FR; Briët E
    Circulation; 1994 Feb; 89(2):635-41. PubMed ID: 8313552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterograft valve replacement experience.
    Bunton RW; Feint JA; Molloy PJ
    Aust N Z J Surg; 1982 Dec; 52(6):550-3. PubMed ID: 6984648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Heart valve prosthesis and anticoagulant treatment. Apropos of 240 patients, including 57 without treatment].
    Ismaïl MB; Houissa R; Cabane J; Richard C; Enriquez-Sarano L; Kafsi N
    Coeur Med Interne; 1978; 17(1):19-27. PubMed ID: 639485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.